Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06848101 · ClinicalTrials.gov registry record · NA

Eye and Carotenoid Augmentation Research and Evaluation (EyeCARE)

A NA study of Vision and Eye Health, sponsored by University of Illinois at Urbana-Champaign.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06848101 is a NA study of Vision and Eye Health that is active but no longer recruiting, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 40 participants, below the 2,086-participant average among 5 other Vision trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06848101, a NA study of Vision and Eye Health, is active but no longer recruiting, sponsored by University of Illinois at Urbana-Champaign.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The primary study outcomes are to investigate the effects of 4-month daily carotenoid complex supplementation on carotenoid status in the macula and skin and visual fatigue among adults 20-45 years of age. Secondary outcomes will examine the supplementation effects on cognitive function.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Carotenoid Group
  • DIETARY_SUPPLEMENT Control (placebo) group

Study Locations (1)

Illinois

  • University of illinois - Urbana

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-03-15
Est. Completion 2025-03-14
Phase NA

What the Registry Record Tells You About NCT06848101

The ClinicalTrials.gov registry entry for NCT06848101 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,086-participant average among 5 other Vision trials with a reported enrollment target (98% lower). The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Vision appearing as the primary indexed condition, and to 2 interventions - of which Carotenoid Group is the first listed.

NCT06848101 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06848101 about?

NCT06848101 is a clinical study titled "Eye and Carotenoid Augmentation Research and Evaluation (EyeCARE)". The primary study outcomes are to investigate the effects of 4-month daily carotenoid complex supplementation on carotenoid status in the macula and skin and visual fatigue among adults 20-45 years of age. Secondary outcomes will examine the supplementation effects on cognitive function.

What is the current status of trial NCT06848101?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-03-15. Estimated completion is 2025-03-14.

What conditions does trial NCT06848101 study?

This clinical trial studies the following conditions: Vision, Eye Health.

What interventions are being tested in trial NCT06848101?

The interventions under investigation include: Carotenoid Group (DIETARY_SUPPLEMENT), Control (placebo) group (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06848101?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06848101 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.